跳至主要内容
临床试验/IRCT20090613002027N12
IRCT20090613002027N12招募中2 期

Efficacy and safety of bupropion in cancer-related fatigue, a randomized double blind placebo controlled clinical trial

Mazandaran University of Medical Scienses0 个研究点目标入组 30 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • Patients suffering from cancer-related fatigue
  • Score of at least 4 based on BFI (Brief Fatigue Inventory) scale (0-10)
  • Fatigue with unknown reason for at least one week and more

排除标准

  • Age under 18
  • History of use of the CNS stimulants and antidepressants
  • History of seizure
  • History of use of erythropoietin in the last six weeks.
  • History of suicide
  • Use of MAOIs (Mono Amino Oxidase Inhibitors) in the last two weeks
  • Liver and renal failure
  • Pregnancy and lactation

研究者

发起方
Mazandaran University of Medical Scienses

相似试验

Efficacy and safety of bupropion in cancer-related... | 临床试验